{"schema_version":"secwatch.filing_event.v1","accession":"0001420800-24-000009","form_type":"8-K","ticker":"ENOV","cik":"0001420800","company_name":"Enovis CORP","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.343529+00:00","generated_at":"2026-06-03T00:15:38.153958+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Enovis Q1 revenue $516M (+27% YoY), adjusted EPS $0.50, raises full-year outlook","bullets":["Net sales of $516M, up 27% reported and 5% proforma YoY; Recon sales +66% reported, +7% proforma.","GAAP net loss from continuing ops $72M ($1.32/share loss); adjusted EPS of $0.50.","Adjusted EBITDA $83M (16.1% of sales), margin expanded 220 bps YoY.","Updated FY2024 guidance: revenue $2.06-2.16B, adj EBITDA $368-383M, adj EPS $2.52-$2.67.","Closed LimaCorporate acquisition; launched Arvis 2.0 and other products at AAOS."],"urls":{"canonical":"https://secwatch.observer/filing/0001420800-24-000009","json":"https://secwatch.observer/filing/0001420800-24-000009.json","markdown":"https://secwatch.observer/filing/0001420800-24-000009.md","text":"https://secwatch.observer/filing/0001420800-24-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420800/000142080024000009/0001420800-24-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420800/000142080024000009/cfx-20240502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T00:15:38.153958+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b38da8b4abee417048df8c975239200ef4906e2","claim":"Enovis CORP reported the first quarter ended March 29, 2024 results: revenue $516 million, net income net loss from continuing operations of $72 million, EPS net loss from continuing operations of $1.32 per share and adjusted earnings per diluted share of $0.50. Guidance raised.","evidence_excerpt":"will host an investor conference call and live webcast to discuss these results today at 8:00 am ET. First Quarter 2024 Financial Results Enovis’ first-quarter net sales of $516 million grew 27% on a reported basis and 5% on a proforma basis from the same quarter in 2023. First-quarter results reflect continued execution in P&R, strong growth in Recon, and the","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420800/000142080024000009/0001420800-24-000009-index.htm","confidence":0.8,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 29, 2024"},{"label":"Revenue","value":"$516 million"},{"label":"Net income","value":"net loss from continuing operations of $72 million"},{"label":"EPS","value":"net loss from continuing operations of $1.32 per share and adjusted earnings per diluted share of $0.50"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}